The internet protocol television (IPTV) market size which was USD 34717.88 million in 2022, reaches USD 66654.47 million by 2030, condemning a CAGR of 17.8%.

Global Harmonic Filter Market, By Type (Active Harmonic Filter, Passive Harmonic Filter, Hybrid Harmonic Filter), Voltage Level (Low-Voltage Harmonic Filters, Medium-Voltage Harmonic Filters, High-Voltage Harmonic Filters), End-User (Industrial, Commercial, Residential), Phase (Single- Phase Harmonic Filter, Three- Phase Harmonic Filter), Country (U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

The Cosmetics Market was valued at USD 268.97 billion in 2023 and is expected to reach up to USD 422.27 billion, with a CAGR of 5.80% by 2031.

Blood Flow Measurement Devices Market to grow at a CAGR 8.44% & value to reach USD 887.88 million by forecast 2028. It fragments by country, product, application, disease and end-user

Plasma Fractionation Market was USD 29,259.96 million in 2023, is expected to reach USD 48,425.11 million by 2031, at a CAGR of 6.5% during the forecast period

Edge Artificial Intelligence (AI) Hardware Market was valued at USD 744.03 million in 2022 and will reach USD 4030.32 million, registering a CAGR of 20.84% by 2030

The Electrosurgery Market growth at a CAGR of 5.55% & expected USD 10.98 billion by 2029. The electrosurgery market is analyzed on the basis of product type, surgery type and end user.

The diabetes care devices market size was USD 31.54 billion in 2023 and it will surpass USD 61.47 billion by 2031, with a CAGR of 8.7% in the forecast period by 2031.

The Non-Cardioselective Beta Blockers Market is expected to grow a healthy CAGR during the forecast period by 2029. It is divided into indication, drugs, target, route of administration, distribution channel and end-user.

The Myxoid Liposarcoma Treatment Market was valued at USD 31.70 billion in 2023 and will reach USD 53.62 billion, with a CAGR of 5.8% by 2031.